97 results on '"Guarnotta G"'
Search Results
2. Role of body shape and metabolic syndrome in symptoms persistence in patients undergoing transurethral resection of the prostate
3. Quality of information and appropriateness of ChatGPT outputs for urological trauma
4. Prostate shape and intravesical prostatic protrusionassessed by magnetic resonance imaging are related to urinary symptoms
5. Major adverse cardiovascular events (MACE) related to phosphodiesterase 5 inhibitors (PDE5I): analysis of real-life data from eudra-vigilance (EV) database
6. Medications mostly associated with haematuria: assessment of the eudravigilance (EV) and food and drug administration (FDA) pharmacovigilance databases entries
7. Medications mostly associated with ejaculatory disorders: assessment of the eudravigilance (EV) and food and drug administration (FDA) pharmacovigilance databases entries
8. Is MRI and fusion biopsies necessary in patients with PSA levels >10 ng/ml?
9. Higher testosterone serum levels are associated with a higher childbirth in patients treated for testicular cancer
10. Role of post voided residual ratio in patients with detrusor underactivity: a pressure flow study analysis
11. Medications mostly associated with urinary tract infections (UTIS): assessment of the eudravigilance (EV) and food and drug administration (FDA) pharmacovigilance databases entries
12. A0857 - Quality of information and appropriateness of ChatGPT outputs for urological trauma
13. A0791 - Role of body shape and metabolic syndrome in symptoms persistence in patients undergoing transurethral resection of the prostate
14. A0793 - Prostate shape and intravesical prostatic protrusionassessed by magnetic resonance imaging are related to urinary symptoms
15. A0083 - Quality of information and appropriateness of Open AI outputs for lithiasis management
16. P105 - Quality of information and appropriateness of Open AI outputs for urinary tract infections
17. Real-life adverse events related to PDE-5 I treatment: Analysis of the EudraVigilance database
18. Medications mostly associated with urinary retention: Assessment of the Eudravigilance (EV) and the Food and Drug Administration (FDA) Pharmacovigilance database entries
19. Cardiovascular adverse events-related to GnRH agonists and GnRH antagonists: Analysis of real-life data from Eudra-Vigilance database
20. Medications mostly associated with haematuria: Assessment of the EudraVigilance (EV) and Food and Drug Administration (FDA) Pharmacovigilance databases entries
21. Medications mostly associated with Urinary Tract Infections (UTIs): assessment of the EudraVigilance (EV) and Food and Drug Administration (FDA) Pharmacovigilance databases entries
22. Medications mostly associated with ejaculatory disorders: Assessment of the EudraVigilance (EV) and Food and Drug Administration (FDA) Pharmacovigilance databases entries
23. Role of inflammatory markers and frailty index as predictors of adverse pathological stage in patients with kidney cancer: a multicenter analysis
24. Role of inflammatory markers and frailty index as predictors of adverse pathological stage andcomplications in patients with upper urinary tract urothelial cancer: a multicenter analysis
25. Sexual adverse events-related to dutasteride e finasteride: analysis of real-life data from Eudra-Vigilance database
26. Sexual adverse events-related to dutasteride e finasteride: Analysis of real-life data from EudraVigilance database
27. Alpha-blockers adverse events: Analysis of real-life data from Eudra-Vigilance
28. Effect of vacation on urinary symptoms in health care workers: an Italian multicenter study
29. Successful trial without catheter development of a clinical nomogram
30. Higher testosterone serum levels are associated with a higher childbirth in patients treated for testicular cancer
31. Successful trial without catheter development of a clinical nomogram
32. Effect of vacation on urinary symptoms in health care workers: An Italian multicenter study
33. Risk factors for acute urinary retention development of a clinical nomogram
34. Successfull trial without catheter development of a clinical nomogram
35. SC113 - Medications mostly associated with urinary tract infections (UTIS): assessment of the eudravigilance (EV) and food and drug administration (FDA) pharmacovigilance databases entries
36. SC38 - Major adverse cardiovascular events (MACE) related to phosphodiesterase 5 inhibitors (PDE5I): analysis of real-life data from eudra-vigilance (EV) database
37. SC31 - Medications mostly associated with haematuria: assessment of the eudravigilance (EV) and food and drug administration (FDA) pharmacovigilance databases entries
38. SC19 - Medications mostly associated with ejaculatory disorders: assessment of the eudravigilance (EV) and food and drug administration (FDA) pharmacovigilance databases entries
39. SC7 - Is MRI and fusion biopsies necessary in patients with PSA levels >10 ng/ml?
40. SC259 - Role of post voided residual ratio in patients with detrusor underactivity: a pressure flow study analysis
41. SC211 - Higher testosterone serum levels are associated with a higher childbirth in patients treated for testicular cancer
42. Using machine learning tools to predict prostate cancer upgrading after robotic radical prostatectomy
43. A1169 - Real-life adverse events related to PDE-5 I treatment: Analysis of the EudraVigilance database
44. A0588 - Medications mostly associated with urinary retention: Assessment of the Eudravigilance (EV) and the Food and Drug Administration (FDA) Pharmacovigilance database entries
45. A0542 - Medications mostly associated with ejaculatory disorders: Assessment of the EudraVigilance (EV) and Food and Drug Administration (FDA) Pharmacovigilance databases entries
46. A0203 - Cardiovascular adverse events-related to GnRH agonists and GnRH antagonists: Analysis of real-life data from Eudra-Vigilance database
47. A0108 - Medications mostly associated with Urinary Tract Infections (UTIs): assessment of the EudraVigilance (EV) and Food and Drug Administration (FDA) Pharmacovigilance databases entries
48. A0105 - Medications mostly associated with haematuria: Assessment of the EudraVigilance (EV) and Food and Drug Administration (FDA) Pharmacovigilance databases entries
49. SC303 - Role of inflammatory markers and frailty index as predictors of adverse pathological stage in patients with kidney cancer: a multicenter analysis
50. SC135 - Role of inflammatory markers and frailty index as predictors of adverse pathological stage andcomplications in patients with upper urinary tract urothelial cancer: a multicenter analysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.